Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of Multiple Ascending Doses of CG400549 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 13 May 2013
At a glance
- Drugs CG 400549 (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Vancomycin-resistant Staphylococcus aureus infections
- Focus Adverse reactions
- 13 May 2013 New source identified and integrated: ClinicalTrials.gov record.
- 11 May 2011 Status changed from planning to completed, according to information in a CrystalGenomics media release.
- 10 May 2010 New trial record